Importance A transcarotid artery revascularization (TCAR) device was approved by the US
Food and Drug Administration in 2015 for carotid revascularization in patients at high risk for …

Background Transcarotid artery revascularization (TCAR) was approved by the Food and
Drug Administration in 2015 for patients with carotid artery stenosis. However, no …

BACKGROUND: In 2015, the FDA approved transcarotid artery revascularization (TCAR) as
an alternative to carotid endarterectomy (CEA) and transfemoral carotid artery stenting (TF …

Background Carotid artery stenting (CAS), including both transfemoral carotid artery stenting
(TFCAS) and transcarotid artery revascularization (TCAR), reimbursement has been limited …

Importance Transcarotid artery revascularization (TCAR) may serve as a safer alternative to
carotid endarterectomy (CEA) for certain patients with carotid artery stenosis. Objective To …

Background Carotid endarterectomy (CEA) and carotid artery stenting (CAS) are accepted
revascularization modalities to treat carotid artery stenosis. Higher incidences of …

Importance Carotid artery stenting has been limited to use in patients with high surgical risk;
outcomes in patients with standard surgical risk are not well known. Objective To compare …

Objective Transcarotid artery revascularization (TCAR) with flow reversal offers a less
invasive option for carotid revascularization in high-risk patients and has the lowest reported …

METHODS: The National Inpatient Database was used for years 2015 to 2019. A
multivariate logistic regression model was used to compare CEA, CAS, and TCAR outcomes …

Objective: Carotid endarterectomy (CEA) remains the gold standard procedure for carotid
revascularization. Transfemoral carotid artery stenting (TFCAS) was introduced as a …